Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.
Status:
Terminated
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if ticagrelor is as effective as clopidogrel in
rate of onset and degree of platelet inhibition for patients with non-ST elevation of acute
coronary syndrome (NSTE-ACS) undergoing ad hoc percutaneous coronary intervention (PCI) with
bivalirudin.